Spire Healthcare Group (SPI) Sets New 12-Month Low at $118.50
Spire Healthcare Group PLC (LON:SPI)’s share price hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 118.50 ($1.55) and last traded at GBX 118.50 ($1.55), with a volume of 2745983 shares changing hands. The stock had previously closed at GBX 128.40 ($1.68).
Several brokerages recently commented on SPI. JPMorgan Chase & Co. decreased their price objective on shares of Spire Healthcare Group from GBX 293 ($3.83) to GBX 256 ($3.35) and set a “neutral” rating for the company in a research report on Tuesday, August 7th. Peel Hunt began coverage on shares of Spire Healthcare Group in a research report on Friday, June 22nd. They issued an “add” rating and a GBX 278 ($3.63) price objective for the company. Barclays lowered shares of Spire Healthcare Group to an “underweight” rating and decreased their price objective for the company from GBX 190 ($2.48) to GBX 130 ($1.70) in a research report on Friday, September 28th. Berenberg Bank reaffirmed a “sell” rating and issued a GBX 120 ($1.57) price objective on shares of Spire Healthcare Group in a research report on Tuesday, September 18th. Finally, Credit Suisse Group raised shares of Spire Healthcare Group to a “neutral” rating and decreased their price objective for the company from GBX 250 ($3.27) to GBX 215 ($2.81) in a research report on Wednesday, August 8th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. Spire Healthcare Group has a consensus rating of “Hold” and a consensus target price of GBX 189 ($2.47).
The firm also recently declared a dividend, which will be paid on Tuesday, December 11th. Shareholders of record on Thursday, November 15th will be given a dividend of GBX 1.30 ($0.02) per share. This represents a yield of 0.78%. The ex-dividend date is Thursday, November 15th.
About Spire Healthcare Group (LON:SPI)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Read More: Earnings Reports
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.